Study Finds Psoriasis Risk Reduction with Greater Intake of Riboflavin
This analysis suggests intake of riboflavin, also known as vitamin B2, shows an association with patients’ risk of developing psoriasis.
This analysis suggests intake of riboflavin, also known as vitamin B2, shows an association with patients’ risk of developing psoriasis.
These data suggest that heart health, as determined by the LC9 assessment, is positively correlated with pulmonary health.
FDA approves 12.5 mg chlorthalidone tablets, enhancing hypertension treatment options and aligning with clinical guidelines for better patient outcomes.
New research reveals Medicaid unwinding disrupts chronic medication access for young adults, risking health and treatment outcomes amid enrollment losses.
HCPLive is a clinical news and information portal, offering physicians specialty and disease-specific resources, conference coverage, and interviews.
Digital inhalers enhance asthma control and reduce severe exacerbations, offering promising benefits with minimal harm for patients struggling with adherence.
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care…
This analysis highlighted the cardiovascular safety of systemic psoriasis drugs using a prospective cohort trial design.
In this iteration of our Month in Review series, we highlight some of the most notable stories covered in April in the dermatology field.
FibroX showed superior performance, interpretability, and potential cost savings relative to FIB-4, improving risk stratification and management in MASLD.
New research uncovers unique brain abnormalities linked to sleep disorders and deprivation, revealing insights into emotional and cognitive impacts.